These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 7730261)
1. EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB. Lomovskaya O; Lewis K; Matin A J Bacteriol; 1995 May; 177(9):2328-34. PubMed ID: 7730261 [TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. Aínsa JA; Blokpoel MC; Otal I; Young DB; De Smet KA; Martín C J Bacteriol; 1998 Nov; 180(22):5836-43. PubMed ID: 9811639 [TBL] [Abstract][Full Text] [Related]
3. Structural basis for the regulation of β-glucuronidase expression by human gut Enterobacteriaceae. Little MS; Pellock SJ; Walton WG; Tripathy A; Redinbo MR Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E152-E161. PubMed ID: 29269393 [TBL] [Abstract][Full Text] [Related]
4. Global transcriptional effects of a suppressor tRNA and the inactivation of the regulator frmR. Herring CD; Blattner FR J Bacteriol; 2004 Oct; 186(20):6714-20. PubMed ID: 15466022 [TBL] [Abstract][Full Text] [Related]
5. Regulation of bacterial drug export systems. Grkovic S; Brown MH; Skurray RA Microbiol Mol Biol Rev; 2002 Dec; 66(4):671-701, table of contents. PubMed ID: 12456787 [TBL] [Abstract][Full Text] [Related]
6. Efflux pump gene expression in Erwinia chrysanthemi is induced by exposure to phenolic acids. Ravirala RS; Barabote RD; Wheeler DM; Reverchon S; Tatum O; Malouf J; Liu H; Pritchard L; Hedley PE; Birch PR; Toth IK; Payton P; San Francisco MJ Mol Plant Microbe Interact; 2007 Mar; 20(3):313-20. PubMed ID: 17378434 [TBL] [Abstract][Full Text] [Related]
7. In Vitro Microevolution and Co-Selection Assessment of Florfenicol Impact on Kerek Á; Török B; Laczkó L; Kardos G; Bányai K; Somogyi Z; Kaszab E; Bali K; Jerzsele Á Antibiotics (Basel); 2023 Dec; 12(12):. PubMed ID: 38136762 [TBL] [Abstract][Full Text] [Related]
8. Types and Mechanisms of Efflux Pump Systems and the Potential of Efflux Pump Inhibitors in the Restoration of Antimicrobial Susceptibility, with a Special Reference to Zack KM; Sorenson T; Joshi SG Pathogens; 2024 Feb; 13(3):. PubMed ID: 38535540 [TBL] [Abstract][Full Text] [Related]
9. In Vitro Microevolution and Co-Selection Assessment of Amoxicillin and Cefotaxime Impact on Kerek Á; Török B; Laczkó L; Somogyi Z; Kardos G; Bányai K; Kaszab E; Bali K; Jerzsele Á Antibiotics (Basel); 2024 Mar; 13(3):. PubMed ID: 38534682 [TBL] [Abstract][Full Text] [Related]
14. Liver's influence on the brain through the action of bile acids. Yeo XY; Tan LY; Chae WR; Lee DY; Lee YA; Wuestefeld T; Jung S Front Neurosci; 2023; 17():1123967. PubMed ID: 36816113 [TBL] [Abstract][Full Text] [Related]
15. Susceptibility Tests and Predictions of Transporter Profile in Staats GJ; Mc Carlie SJ; Boucher-van Jaarsveld CE; Bragg RR Microorganisms; 2022 Nov; 10(11):. PubMed ID: 36422327 [TBL] [Abstract][Full Text] [Related]
16. Environmental complexity is more important than mutation in driving the evolution of latent novel traits in E. coli. Karve S; Wagner A Nat Commun; 2022 Oct; 13(1):5904. PubMed ID: 36202805 [TBL] [Abstract][Full Text] [Related]
17. Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria. Sionov RV; Steinberg D Microorganisms; 2022 Jun; 10(6):. PubMed ID: 35744757 [TBL] [Abstract][Full Text] [Related]
18. Analysis of multidrug efflux transporters in resistance to fatty acid salts reveals a TolC-independent function of EmrAB in Salmonella enterica. Yoneda T; Sakata H; Yamasaki S; Hayashi-Nishino M; Nishino K PLoS One; 2022; 17(4):e0266806. PubMed ID: 35421142 [TBL] [Abstract][Full Text] [Related]
19. Function and Inhibitory Mechanisms of Multidrug Efflux Pumps. Nishino K; Yamasaki S; Nakashima R; Zwama M; Hayashi-Nishino M Front Microbiol; 2021; 12():737288. PubMed ID: 34925258 [TBL] [Abstract][Full Text] [Related]
20. Multiple Novel Traits without Immediate Benefits Originate in Bacteria Evolving on Single Antibiotics. Karve S; Wagner A Mol Biol Evol; 2022 Jan; 39(1):. PubMed ID: 34865131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]